TB-500 , 43 amino asit uzunluundaki Timosin-Beta-4'n aktif aktin balayc blgesini yanstan sentetik bir heptapeptittir (Ac-LKKTETQ) 5
Oral and injectable forms vary in bioavailability, effectiveness, convenience, and evidence strength
Liver and kidney function tests verify that these organs are processing the peptide normally
TB-500 is a truncated version of thymosin beta 4 and is receiving increasing attention for its healing properties 2
In a recent study, FOXO4-DRI decreased levels of p53, p21, and p16 in the testes of aged mice, when compared to young mice (Zhang et al., 2020)
While a warning letter does not necessarily reflect product quality, it signals regulatory attention that some researchers factor into vendor risk assessment